This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Mediware Receives Updated FDA Clearance For Core Blood Products

Stocks in this article: MEDW

New versions of LifeTrak® and HCLL™ Transfusion gain 510(k) clearance. Software to be demonstrated at upcoming AABB Annual Meeting & CTTxpo, October 6-9.

LENEXA, Kan., Oct. 4, 2012 (GLOBE NEWSWIRE) -- Mediware Information Systems, Inc. (Nasdaq:MEDW) announced that the 2012 versions of the company's core blood management software products, including LifeTrak® and HCLL® Transfusion, have received updated 510(k) clearance by the US FDA. The software systems are used by more than 500 hospital and blood center facilities in the United States, Canada, Ireland, and Singapore to support blood donor management; blood testing, product manufacturing and distribution; and patient testing and transfusions. Both products were also selected by the US Department of Defense to support effective blood management in Military Health facilities worldwide.

Mediware has been a provider of blood management software and services for 40 years, and is credited with having the first transfusion software system 510(k) cleared for use in hospitals by the US FDA. Since this initial effort, the company has continued to invest in innovations that streamline data and workflow management associated with the entire blood supply chain, from donor recruitment to patient transfusion. The product portfolio was recently expanded through the acquisition of Strategic Healthcare Group to include consulting and benchmarking that improve the utilization of blood products and help lower hospital costs.

The latest versions of Mediware blood management software cleared by the US FDA offer customers robust, enterprise-wide capabilities that enable them to operate more efficiently, while still focusing on safety and quality. This included multiple time zone and expanded multi-facility capabilities that are important in supporting large, enterprise-wide needs where critical blood and patient data is shared across multiple facilities with users seeing and processing data at local time. These capabilities are especially important for the Military Health organizations that will deploy the software worldwide.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,164.95 -251.90 -1.45%
S&P 500 1,994.99 -26.26 -1.30%
NASDAQ 4,635.24 -48.1670 -1.03%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs